Related Experiment Video
Updated: Jun 4, 2026

Purification and Expansion of Mouse Invariant Natural Killer T Cells for in vitro and in vivo Studies
Published on: February 15, 2021
Type I interferon-activated NK cells control polycythemia vera in vivo
Johanna Lossa1, Tina M Schnöder2, Zora Ronge3
1University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Natural killer (NK) cells are key immune responders to Interferon-alpha (IFN-a) therapy in Polycythemia vera (PV). These cells control disease progression by targeting cancerous stem cells, offering new therapeutic strategies for myeloproliferative neoplasms (MPN).
Area of Science:
- Immunology
- Hematology
- Cancer Biology
Background:
- Polycythemia vera (PV) is a myeloproliferative neoplasm (MPN) characterized by excessive red blood cell production.
- Interferon-alpha (IFN-a) shows therapeutic promise in MPNs, but its mechanism of action is not fully understood.
- Natural killer (NK) cells are crucial immune cells with roles in cancer surveillance.
Purpose of the Study:
- To elucidate the role of NK cells in IFN-a therapy for PV.
- To investigate the mechanism by which NK cells exert therapeutic effects in PV.
- To explore the potential of NK cell-based therapies for MPNs.
Main Methods:
- Utilized a transgenic mouse model of PV.
- Analyzed NK cell populations (CD27+, CD56bright) in PV patients and mice treated with IFN-a.
- Performed NK cell depletion studies in vivo and in vitro killing assays of Jak2VF mutant hematopoietic stem and progenitor cells (HSPCs).
Main Results:
- IFN-a treatment expanded CD27+ NK cells in mouse bone marrow and increased CD56bright NK cells in PV patients, correlating with molecular response.
- Depletion of NK cells abolished the therapeutic efficacy of IFN-a, and NK cells killed PV HSPCs via TNF-a.
- PV mice lacking NK cells or type-I IFN receptor on NK cells exhibited accelerated disease progression, indicating basal NK cell activity is vital for immune surveillance.
Conclusions:
- NK cells are essential immune effectors mediating IFN-a's therapeutic benefits in PV.
- Basal type-I interferon signaling through NK cells is critical for controlling MPN progression.
- Targeting NK cell activation presents a promising strategy for improving MPN treatment outcomes.
Related Concept Videos
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Inhibitors of Viral Protein Synthesis
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Regulation of Hematopoietic Stem Cells
